Evidence map›Paper›PMID 36906721›Full record

Trial reportPediatric research2023

Impact of two ketogenic diet types in refractory childhood epilepsy.

Ali M El-Shafie, Wael A Bahbah, Sameh A Abd El Naby, Zein A Omar, Elsayedamr M Basma, Aya A A Hegazy, Heba M S El Zefzaf

Open access · hybridFull text readRandomized Controlled Trial
In one paragraph

Trial report in Pediatric research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ali M El-ShafieDepartment of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
Wael A BahbahDepartment of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt. wael_bahbah@yahoo.com.ORCID 0000-0001-6145-0572
Sameh A Abd El NabyDepartment of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
Zein A OmarDepartment of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
Elsayedamr M BasmaDepartment of Bioinformatics and Medical Statistics, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Aya A A HegazyDepartment of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
Heba M S El ZefzafDepartment of Pediatrics, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
Menoufia University · EGAlexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKetogenic diet (KD) refers to any diet in which food composition induces a ketogenic state of human metabolism.

objectiveTo assess short- and long-term efficacy, safety, and tolerability of KD [classic KD and modified Atkins diet (MAD)] in childhood drug-resistant epilepsy (DRE) and to investigate the effect of KD on electroencephalographic (EEG) features of children with DRE.

methodsForty patients diagnosed with DRE according to International League Against Epilepsy were included and randomly assigned into classic KD or MAD groups. KD was initiated after clinical, lipid profile and EEG documentation, and regular follow-up was done for 24 months.

resultsOut of 40 patients with DRE, 30 completed this study. Both classic KD and MAD were effective in seizure control as 60% in classic KD group and 53.33% in MAD group became seizure free, and the remaining showed ≥50% seizure reduction. Lipid profile remained within acceptable levels throughout the study period in both groups. Adverse effects were mild and managed medically with an improvement of growth parameters and EEG during the study period.

conclusionsKD is an effective and safe non-pharmacologic, non-surgical therapy for the management of DRE with a positive impact on growth and EEG. IMPACT: Both common types of KD (classic KD and MAD) are effective for DRE, but unfortunately, nonadherence and dropout rates are frequent. High serum lipid profile (cardiovascular AE) is often suspected in children following a high-fat diet, but lipid profile remained in the acceptable level up to 24 months. Therefore, KD constitutes a safe treatment. KD had a positive impact on growth, despite inconsistent results of the KD's effect on growth. In addition to showing strong clinical effectiveness, KD also considerably decreased the frequency of interictal epileptiform discharges and enhanced the EEG background rhythm.

Indexed as

Diet, KetogenicDrug Resistant EpilepsyEpilepsyChildDiet, Carbohydrate-RestrictedHumansLipidsSeizuresTreatment OutcomeLipids

Identifiers

PMID36906721
PMCPMC10007663
OpenAlexW4323923940

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read283
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.